A detailed history of Bell Investment Advisors, Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 159 shares of EXEL stock, worth $5,377. This represents 0.0% of its overall portfolio holdings.

Number of Shares
159
Previous 184 13.59%
Holding current value
$5,377
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$21.96 - $27.6 $549 - $690
-25 Reduced 13.59%
159 $4,000
Q2 2024

Aug 07, 2024

SELL
$20.34 - $23.73 $447 - $522
-22 Reduced 10.68%
184 $4,000
Q1 2024

May 08, 2024

BUY
$20.17 - $23.93 $443 - $526
22 Added 11.96%
206 $4,000
Q3 2023

Nov 08, 2023

BUY
$19.04 - $22.74 $1,199 - $1,432
63 Added 52.07%
184 $4,000
Q1 2023

May 10, 2023

BUY
$16.3 - $19.41 $505 - $601
31 Added 34.44%
121 $2,000
Q4 2022

Feb 08, 2023

BUY
$14.96 - $17.39 $448 - $521
30 Added 50.0%
90 $1,000
Q3 2022

Nov 09, 2022

BUY
$15.68 - $22.27 $580 - $823
37 Added 160.87%
60 $1,000
Q2 2022

Aug 12, 2022

BUY
$17.44 - $23.16 $401 - $532
23 New
23 $0
Q4 2021

Feb 14, 2022

SELL
$15.84 - $21.88 $427 - $590
-27 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$16.3 - $21.14 $440 - $570
27 New
27 $1,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.